PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Biogen stock at 5.22%, Natera at 5.19%, Gilead Sciences at 5.13%, Royalty Pharma at 5.01%, and Regeneron Pharmaceuticals at 4.98%.

Total Holdings

Top 10 Percentage

45.96%

Asset Class

Equity

ETF Category

Health

Assets

404.80M

PE Ratio

23.55

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	BIIB	Biogen Inc.	5.22%	97,463
2	NTRA	Natera, Inc.	5.19%	63,897
3	GILD	Gilead Sciences, Inc.	5.13%	144,633
4	RPRX	Royalty Pharma plc	5.01%	346,648
5	REGN	Regeneron Pharmaceuticals, Inc.	4.98%	25,818
6	VRTX	Vertex Pharmaceuticals Incorporated	4.95%	38,921
7	ILMN	Illumina, Inc.	4.87%	95,636
8	AMGN	Amgen Inc.	4.53%	48,651
9	SRPT	Sarepta Therapeutics, Inc.	3.13%	620,303
10	NBIX	Neurocrine Biosciences, Inc.	2.95%	76,529
11	NVAX	Novavax, Inc.	2.89%	1,243,231
12	BMRN	BioMarin Pharmaceutical Inc.	2.88%	177,491
13	EXEL	Exelixis, Inc.	2.87%	206,910
14	PTGX	Protagonist Therapeutics, Inc.	2.85%	77,937
15	HALO	Halozyme Therapeutics, Inc.	2.84%	107,360
16	QGEN	Qiagen N.V.	2.82%	268,866
17	TGTX	TG Therapeutics, Inc.	2.82%	211,761
18	UTHR	United Therapeutics Corporation	2.78%	22,631
19	ARDX	Ardelyx, Inc.	2.74%	3,104,786
20	INCY	Incyte Corporation	2.71%	90,477
21	VCYT	Veracyte, Inc.	2.69%	266,490
22	ANAB	AnaptysBio, Inc.	2.67%	201,066
23	ACAD	ACADIA Pharmaceuticals Inc.	2.64%	383,915
24	RGEN	Repligen Corporation	2.63%	64,594
25	MRNA	Moderna, Inc.	2.62%	73,884

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now

As of Sep 14, 2026